BACKGROUND: Minimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hemorrhage Evacuation (MISTIE III). OBJECTIVE: To assess the accuracy of catheter placement and efficacy of hematoma evacuation in relation to surgical approach and surgeon experience. METHODS: We performed a trial midpoint interim assessment of 123 cases that underwent the surgical procedure. Accuracy of catheter placement was prospectively assessed by the trial Surgical Center based on prearticulated criteria. Hematoma evacuation efficacy was evaluated based on absolute volume reduction, percentage hematoma evacuation, and reaching the target end-of-treatment volume of <15 mL. One of 3 surgical trajectories was used: anterior (A), posterior (B), and lobar (C). Surgeons were classified based on experience with the MISTIE procedure as prequalified, qualified with probation, and fully qualified. RESULTS: The average hematoma volume was 49.7 mL (range 20.0-124), and the mean evacuation rate was 71% (range 18.4%-99.8%). First placed catheters were 58% in good position, 28% suboptimal (but suitable to dose), and 14% poor (requiring repositioning). Posterior trajectory (B) was associated with significantly higher rates of poor placement (35%, P = .01). There was no significant difference in catheter placement accuracy among surgeons of varying experience. Hematoma evacuation efficacy was not significantly different among the 3 surgical approaches or different surgeons' experience. CONCLUSION: Ongoing surgical education and quality monitoring in MISTIE III have resulted in consistent rates of hematoma evacuation despite technical challenges with the surgical approaches and among surgeons of varying experience.
RCT Entities:
BACKGROUND: Minimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hemorrhage Evacuation (MISTIE III). OBJECTIVE: To assess the accuracy of catheter placement and efficacy of hematoma evacuation in relation to surgical approach and surgeon experience. METHODS: We performed a trial midpoint interim assessment of 123 cases that underwent the surgical procedure. Accuracy of catheter placement was prospectively assessed by the trial Surgical Center based on prearticulated criteria. Hematoma evacuation efficacy was evaluated based on absolute volume reduction, percentage hematoma evacuation, and reaching the target end-of-treatment volume of <15 mL. One of 3 surgical trajectories was used: anterior (A), posterior (B), and lobar (C). Surgeons were classified based on experience with the MISTIE procedure as prequalified, qualified with probation, and fully qualified. RESULTS: The average hematoma volume was 49.7 mL (range 20.0-124), and the mean evacuation rate was 71% (range 18.4%-99.8%). First placed catheters were 58% in good position, 28% suboptimal (but suitable to dose), and 14% poor (requiring repositioning). Posterior trajectory (B) was associated with significantly higher rates of poor placement (35%, P = .01). There was no significant difference in catheter placement accuracy among surgeons of varying experience. Hematoma evacuation efficacy was not significantly different among the 3 surgical approaches or different surgeons' experience. CONCLUSION: Ongoing surgical education and quality monitoring in MISTIE III have resulted in consistent rates of hematoma evacuation despite technical challenges with the surgical approaches and among surgeons of varying experience.
Authors: Paul Vespa; Daniel Hanley; Joshua Betz; Alan Hoffer; Johnathan Engh; Robert Carter; Peter Nakaji; Chris Ogilvy; Jack Jallo; Warren Selman; Amanda Bistran-Hall; Karen Lane; Nichol McBee; Jeffery Saver; Richard E Thompson; Neil Martin Journal: Stroke Date: 2016-10-06 Impact factor: 7.914
Authors: William E Whitehead; Andrew Jea; Shobhan Vachhrajani; Abhaya V Kulkarni; James M Drake Journal: J Neurosurg Date: 2007-11 Impact factor: 5.115
Authors: L M Auer; W Deinsberger; K Niederkorn; G Gell; R Kleinert; G Schneider; P Holzer; G Bone; M Mokry; E Körner Journal: J Neurosurg Date: 1989-04 Impact factor: 5.115
Authors: W Andrew Mould; J Ricardo Carhuapoma; John Muschelli; Karen Lane; Timothy C Morgan; Nichol A McBee; Amanda J Bistran-Hall; Natalie L Ullman; Paul Vespa; Neil A Martin; Issam Awad; Mario Zuccarello; Daniel F Hanley Journal: Stroke Date: 2013-02-07 Impact factor: 7.914
Authors: Issam A Awad; Sean P Polster; Julián Carrión-Penagos; Richard E Thompson; Ying Cao; Agnieszka Stadnik; Patricia Lynn Money; Maged D Fam; Janne Koskimäki; Romuald Girard; Karen Lane; Nichol McBee; Wendy Ziai; Yi Hao; Robert Dodd; Andrew P Carlson; Paul J Camarata; Jean-Louis Caron; Mark R Harrigan; Barbara A Gregson; A David Mendelow; Mario Zuccarello; Daniel F Hanley Journal: Neurosurgery Date: 2019-06-01 Impact factor: 4.654
Authors: Daniel F Hanley; Richard E Thompson; Michael Rosenblum; Gayane Yenokyan; Karen Lane; Nichol McBee; Steven W Mayo; Amanda J Bistran-Hall; Dheeraj Gandhi; W Andrew Mould; Natalie Ullman; Hasan Ali; J Ricardo Carhuapoma; Carlos S Kase; Kennedy R Lees; Jesse Dawson; Alastair Wilson; Joshua F Betz; Elizabeth A Sugar; Yi Hao; Radhika Avadhani; Jean-Louis Caron; Mark R Harrigan; Andrew P Carlson; Diederik Bulters; David LeDoux; Judy Huang; Cully Cobb; Gaurav Gupta; Ryan Kitagawa; Michael R Chicoine; Hiren Patel; Robert Dodd; Paul J Camarata; Stacey Wolfe; Agnieszka Stadnik; P Lynn Money; Patrick Mitchell; Rosario Sarabia; Sagi Harnof; Pal Barzo; Andreas Unterberg; Jeanne S Teitelbaum; Weimin Wang; Craig S Anderson; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Wendy Ziai; Mario Zuccarello; Issam A Awad Journal: Lancet Date: 2019-02-07 Impact factor: 79.321
Authors: Eliza H Hersh; Yakov Gologorsky; Alex G Chartrain; J Mocco; Christopher P Kellner Journal: Curr Neurol Neurosci Rep Date: 2018-05-09 Impact factor: 5.081
Authors: Andrew N Hall; Bradley Weaver; Eric Liotta; Matthew B Maas; Roland Faigle; Daniel K Mroczek; Andrew M Naidech Journal: Neurocrit Care Date: 2021-02 Impact factor: 3.210
Authors: Azmil H Abdul-Rahim; David Alexander Dickie; Johann R Selvarajah; Kennedy R Lees; Terence J Quinn Journal: Trials Date: 2019-02-08 Impact factor: 2.279
Authors: Gregory J Bix; Justin F Fraser; William J Mack; S Thomas Carmichael; Miguel Perez-Pinzon; Halina Offner; Lauren Sansing; Francesca Bosetti; Cenk Ayata; Keith R Pennypacker Journal: Transl Stroke Res Date: 2018-04-10 Impact factor: 6.829